Quarter Period Statement Of Income

Kringle Pharma,Inc. - Filing #7290853

Concept 2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2023-10-01 to
2024-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
2022-10-01 to
2023-09-30
Quarter period statement of income
Statement of income
Net sales
80,038,000 JPY
69,250,000 JPY
Gross profit (loss)
80,038,000 JPY
69,250,000 JPY
Selling, general and administrative expenses
897,920,000 JPY
958,012,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
-817,882,000 JPY
-888,762,000 JPY
Non-operating income
Interest income
10,000 JPY
5,000 JPY
Non-operating income
62,920,000 JPY
43,431,000 JPY
Non-operating expenses
Non-operating expenses
JPY
7,330,000 JPY
Ordinary profit (loss)
-754,961,000 JPY
-852,660,000 JPY
Profit (loss) before income taxes
-754,961,000 JPY
-852,660,000 JPY
Income taxes - current
1,491,000 JPY
1,490,000 JPY
Income taxes
1,491,000 JPY
1,490,000 JPY
Profit (loss)
-756,453,000 JPY
-756,453,000 JPY
-756,453,000 JPY
-756,453,000 JPY
-854,151,000 JPY
-854,151,000 JPY
-854,151,000 JPY
-854,151,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.